Lifitegrast Ophthalmic Solution 5.0% Versus Placebo for Treatment of Dry Eye Disease

Ophthalmology - Netherlands
doi 10.1016/j.ophtha.2015.08.001
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Elsevier BV

Related search

Real-World Treatment Patterns of Cyclosporine Ophthalmic Emulsion and Lifitegrast Ophthalmic Solution Among Patients With Dry Eye

Clinical Ophthalmology
Ophthalmology
2019English

Rebamipide Ophthalmic Solution Modulates the Ratio of T�helper Cell 17/Regulatory T Cells in Dry Eye Disease Mice

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Efficacy and Safety of Retinol Palmitate Ophthalmic Solution in the Treatment of Dry Eye: A Japanese Phase II Clinical Trial

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Etiology, Prevalence, and Treatment of Dry Eye Disease

Clinical Ophthalmology
Ophthalmology
2009English

Thymosin Beta 4 Ophthalmic Solution for Dry Eye: A Randomized, Placebo-Controlled, Phase II Clinical Trial Conducted Using the Controlled Adverse Environment (CAE™) Model

Clinical Ophthalmology
Ophthalmology
2015English

Treatment of Refractory Dry Eye Associated With Graft Versus Host Disease With 0.03% Tacrolimus Eyedrops

Journal of Ocular Pharmacology and Therapeutics
OphthalmologyPharmacology
2013English

Review of Moxifloxacin Hydrochloride Ophthalmic Solution in the Treatment of Bacterial Eye Infections

Clinical Ophthalmology
Ophthalmology
2008English

Six Months' Treatment With Lifitegrast in Patients With Moderate-To-Severe Symptomatic Dry Eye: A Retrospective Chart Review

Clinical Ophthalmology
Ophthalmology
2019English

Diagnostic Tools for Dry Eye Disease

European Ophthalmic Review
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy